The Federal Trade Commission (FTC) announced yesterday that it would not contest the acquisition, but the agency is still investigating potential anti-competitive effects and privacy concerns raised by Amazon’s access to health data. An FTC official disclosed to CNN that the agency would caution Amazon that it is closing the purchase at its own risk and may still face a government challenge later.
